Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Risa Kikuyama"'
Autor:
Kyoichi Kato, Ken Fukunaga, Masaki Iimuro, Koji Yoshida, Takayuki Matsumoto, Nobuyuki Hida, Shiro Nakamura, Kazuko Nagase, Naohisa Takeda, Koji Kamikozuru, Kazutoshi Hori, Hiroto Miwa, Risa Kikuyama, Hiroki Ikeuchi, Yoshio Ohda, Yoko Yokoyama
Publikováno v:
Inflammatory Bowel Diseases. 18:1617-1623
Background: Infliximab (IFX) is effective for remission induction and maintenance of Crohn's disease (CD). This trial assessed the efficacy of scheduled maintenance IFX monotherapy to prevent postoperative CD recurrence. Methods: Thirty-one CD patien
Autor:
Koji Yoshida, Hiroto Miwa, Nobuyuki Hida, Kyoichi Kato, Yoko Yokoyama, Ken Fukunaga, Risa Kikuyama, Naohisa Takeda, Takayuki Matsumoto, Koji Kamikozuru, Shiro Nakamura, Kazuko Nagase, Masaki Iimuro, Yoshio Ohda
Publikováno v:
Journal of Clinical Apheresis. 26:326-331
Background: Leukocytapheresis (LCAP) is used as an adjunct therapy for patients with active ulcerative colitis (UC). Although, LCAP is routinely performed at 3,000 mL per session, we were interested to see that if this can be replaced with bodyweight
Autor:
Hiroto Miwa, Koji Yoshida, Yoko Yokoyama, S Nakamura, Koji Kamikozuru, Hiroki Ikeuchi, Kyouichi Kato, Kazuko Nagase, Takayuki Matsumoto, Ken Fukunaga, Masaki Iimuro, Risa Kikuyama, Yoshio Ohda, Nobuyuki Hida
Publikováno v:
Cytokine. 56:466-470
The CD4+CD25High T-cell phenotype has an essential immunoregulatory role, while the CD4+CD28null T-cell reflects immune pathology. We investigated the profiles of the CD4+CD25High and the CD4+CD28null T-cell phenotypes in patients with ulcerative col
Autor:
Koji Yoshida, Yoshio Ohda, Yoko Yokoyama, Risa Kikuyama, Takayuki Matsumoto, Koji Kamikozuru, Kazuko Nagase, Nobuyuki Hida, Ken Fukunaga, Shin-ichiro Kashiwamura, Naohisa Takeda, Kyoichi Kato, Masaki Iimuro, Tomoaki Kono, Hiroto Miwa
Publikováno v:
Therapeutic Apheresis and Dialysis. 15:367-373
In Japan, adsorptive granulocyte/monocyte apheresis (GMA) is an approved treatment option in patients with active Crohn's disease (CD). However, there is inadequate knowledge regarding the mechanism(s) of therapeutic effects of this non-pharmacologic
Autor:
Risa Kikuyama, Takayuki Matsumoto, Mikio Kawai, Koji Yoshida, Masaki Iimuro, Koji Kamikozuru, Kyoichi Kato, Hiroto Miwa, Naohisa Takeda, Yoshiyuki Takei, Nobuyuki Hida, Shiro Nakamura, Kazuko Nagase, Tomoaki Kono, Ken Fukunaga, Yoshio Ohda, Koji Nogami, Yoko Yokoyama
Publikováno v:
Therapeutic Apheresis and Dialysis. 15:360-366
Granulocyte/monocyte adsorption (GMA) has been introduced as an adjunct intervention for active ulcerative colitis (UC) patients. The processed blood volume (PV) per GMA session is an important factor for its efficacy because depletion of elevated/ac
Autor:
Koji Yoshida, Yoshio Ohda, Masaki Iimuro, Risa Kikuyama, Hiroto Miwa, Takayuki Matsumoto, Koji Kamikozuru, Nobuyuki Hida, Naohisa Takeda, Shin-ichiro Kashiwamura, Ken Fukunaga, Yoko Yokoyama, Kyoichi Kato
Publikováno v:
Gut and Liver. 5:37-45
†‡ § Background/Aims: Infliximab (IFX), an antibody to tumor necrosis factor, (TNF)-α has effi cacy in treating Crohn’s disease (CD). However, knowledge of the potential effects of IFX on patients’ immune profi les is lacking. The purpose o
Autor:
Koji Yoshida, Risa Kikuyama, Koji Kamikozuru, Hiroto Miwa, Ken Fukunaga, Shiro Nakamura, Kazuko Nagase, Takayuki Matsumoto, Yoshiyuki Takei, Yoko Yokoyama
Publikováno v:
Journal of Clinical Apheresis. 25:226-228
Background: This is the first report on a case of Crohn's disease (CD), who was successfully maintained with a combination of infliximab (IFX) and selective depletion of granulocytes/monocytes by adsorption (GMA). Case: A 33-year-old female with CD a
Autor:
Risa, Kikuyama, Ken, Fukunaga, Mikio, Kawai, Yoko, Yokoyama, Koji, Kamikozuru, Nobuyuki, Hida, Yoshio, Ohda, Naohisa, Takeda, Koji, Yoshida, Masaki, Iimuro, Kyoichi, Kato, Tomoaki, Kono, Koji, Nogami, Kazuko, Nagase, Shiro, Nakamura, Yoshiyuki, Takei, Hiroto, Miwa, Takayuki, Matsumoto
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 15(4)
Granulocyte/monocyte adsorption (GMA) has been introduced as an adjunct intervention for active ulcerative colitis (UC) patients. The processed blood volume (PV) per GMA session is an important factor for its efficacy because depletion of elevated/ac
Autor:
Kazuko, Nagase, Ken, Fukunaga, Shinichiro, Kashiwamura, Tomoaki, Kono, Koji, Kamikozuru, Yoko, Yokoyama, Nobuyuki, Hida, Yoshio, Ohda, Naohisa, Takeda, Koji, Yoshida, Masaki, Iimuro, Risa, Kikuyama, Kyoichi, Kato, Hiroto, Miwa, Takayuki, Matsumoto
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 15(4)
In Japan, adsorptive granulocyte/monocyte apheresis (GMA) is an approved treatment option in patients with active Crohn's disease (CD). However, there is inadequate knowledge regarding the mechanism(s) of therapeutic effects of this non-pharmacologic
Autor:
Hiroto Miwa, Koji Yoshida, Naohisa Takeda, Yoko Yokoyama, Kyoichi Kato, Masaki Iimuro, Ken Fukunaga, Risa Kikuyama, Koji Kamikozuru, Takayuki Matsumoto, Nobuyuki Hida, Shiro Nakamura, Yoshio Ohda
Publikováno v:
Gastroenterology. 140:S-261